About this trial
This clinical study is designed to evaluate whether Transcutaneous Electrical Nerve Stimulation (TENS) is an effective, non-drug method to relieve postpartum uterine pain during breastfeeding in multiparous women (women who have given birth multiple times). Breastfeeding in the first 48 hours after delivery often triggers strong, painful uterine contractions due to the natural release of oxytocin. While standard care typically relies on pain-relief medications, this study investigates if TENS, a safe, low-cost device that sends gentle electrical impulses through small skin patches, can significantly reduce this pain and decrease the need for systemic medications. Participants will be randomly assigned to either receive standard postpartum pain medications or use a TENS device during two consecutive breastfeeding sessions. Researchers will measure and compare the peak pain levels between both groups using a standard 0 to 10 pain scale. The aim is examining whether TENS will significantly reduce postpartum uterine pain during breastfeeding and decrease medication use compared with standard care.
Eligibility criteria
Qualifiers
Maternal Age above 18
Term delivery (37 weeks or more)
Vaginal delivery within the past 48 hours.
Multiparous women (2 or more previous births)
Disqualifiers
Contraindication to TENS (pacemaker, epilepsy, active infection, uncontrolled hyper / hypotension.)
Chronic analgesia use
Severe complications requiring intervention (severe PPH) or intensive care
Skin lesions, infections, or scars at proposed electrode sites
Trial design
Treatments tested in this trial
- Transcutaneous Electrical Nerve Stimulation (TENS)